EVERLON (EVERLON) Fair Value & Analysis
IN · Market cap ₹885M
Fair value as of: Jul 5, 2026
From 24 valuation models · updated today
Share price +15.6% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹84.11 – ₹152.70 · fair‑value band ₹20.54 – ₹35.59 · the ₹119.95 price screens above the ₹27.38 fair value. As of Jul 5, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
EVERLON (EVERLON) currently trades at ₹119.95, while our model-based Fair Value estimate is ₹27.38 — implying the stock looks roughly 77.2% overvalued today. We read business quality at 41/100 (below-average quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Net debt stands at ₹43.2M. The stock trades on a trailing P/E of 74.4. Fundamentals as of Jul 5, 2026
Our scenario range runs from ₹20.54 (bear case) to ₹35.59 (bull case); at ₹119.95, the current price sits above that range. The share trades about 16% below its 52-week high and 55% above its 52-week low.
Key figures & financial health
Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
EVERLON reported revenue of ₹131M in FY2025 versus ₹340M in FY2021, a compound −21.2%/yr. Reported net income was ₹11.9M in FY2025, compounding +94.6%/yr from FY2021.
Is EVERLON fairly valued? → Check now
Explore undervalued stocks
Frequently asked questions
Is EVERLON (EVERLON) undervalued?
What is the fair value of EVERLON?
What is the quality score of EVERLON?
What is the net profit margin of EVERLON?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.